EON
EON is an electrostatics comparison program. It compares electrostatic potential maps of pre-aligned molecules and determines the Tanimoto measures for the comparison.
As the electrostatic potential of molecules is not strongly linked to the molecular graph, EON can screen molecular databases for electrostatic similarity to a lead compound to identify lead-hops.
In particular, the electrostatic comparison program EON has shown promise in identifying leads and tool compounds… -- Boström et al. (J. Med. Chem. 2013)
Features
- Identifies molecules with high electrostatic similarity
- Reports rigorous Tanimoto measure between electrostatic grids
- Offers various charge models; user-defined models may also be used
- Integrates well with ROCS®
- Distributed processing via MPI for all supported platforms
- Available as both an application and a toolkit, as well as on the cloud
Since the input molecules must already be aligned, EON is suitable for analyzing the output structures from programs such as ROCS, thus yielding compounds with similar shape and electrostatics.
EON contributes significantly to lead generation and library design. In a published study, Abbott scientists reported that EON's post-processing of ROCS hits helped them lead-hop a MCH-1 series that had demonstrated in vivo potency issues [1]. In a chemical genomics project directed toward antagonists for NAADP, EON was used in complement to ROCS to identify a low nanomolar binder to the NAADP receptor [2].
For more detailed information on EON, check out the link below:
DocumentationReferences
- The Use of Three-Dimensional Shape and Electrostatic Similarity Searching in the Identification of a Melanin-Concentrating Hormone Receptor 1 Antagonist S. Muchmore, A. J. Souers, I. Akritopoulou-Zanze, Chem. Biol. Drug Des., 2006, 67, 174.
- Identification of a chemical probe for NAADP by virtual screening E. Naylor, A. Arredouani, S.R. Vasudevan, A.M. Lewis, R. Parkesh, A. Mizote, D. Rosen, J.M. Thomas, M. Izumi, A. Ganesan, A. Galione and G.C. Churchill, Nature Chemical Biology, 2009, 5, 280-292.
- Potent Fibrinolysis Inhibitor Discovered by Shape and Electrostatic Complementarity to the Drug Tranexamic Acid Jonas Boström, J. Andrew Grant, Ola Fjellström, Anders Thelin, David Gustaffson, J. Med Chem., 2013, 56, 3273-3280.
miniCUP San Francisco 2024
BAGIM Holiday Event
miniCUP Boston 2024
OpenEye Releases Additional Virtual Screening COVID-19 Data to Public
Accelerating Similarity and Substructure Searches
miniWebinar: Opening up the druggable universe one cryptic pocket at a time
CUP XXIV - Santa Fe March 4-6, 2025
Essentials of Computational Drug Discovery | Sep-Dec 2024
Easier is Better
Relative Binding Free Energy with Non-Equilibrium Switching in Orion
OpenEye deploys the Orion platform to find COVID-19 therapeutics
Conversations at CUP: Paul Hawkins & John D. Chodera
Conversations at CUP: Geoff Skillman & Charlotte Deane
CCDC’s GOLD Now Available on Orion®
Conversations at CUP: Anthony Nicholls & Christian Cortis
Orion Integrates Synple Chem to Generate Hits On-Demand